Australia’s highest court sets date for Myriad hearing
11-06-2015
Myriad cancer patent upheld in Australia
08-09-2014
Phillip Minnis / Shutterstock.com (High Court of Australia, pictured)
Australia’s highest court has said that naturally occurring nucleic acid molecules are not patentable, overturning a lower court ruling.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Myriad Genetics, Yvonne D’Arcy, patent, BRCA1, High Court of Australia
